Cargando…

Detection of low frequency FGFR3 mutations in the urine of bladder cancer patients using next-generation deep sequencing

Biological fluid-based noninvasive biomarker assays for monitoring and diagnosing disease are clinically powerful. A major technical hurdle for developing these assays is the requirement of high analytical sensitivity so that biomarkers present at very low levels can be consistently detected. In the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Millholland, John M, Li, Shuqiang, Fernandez, Cecilia A, Shuber, Anthony P
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2012
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3806441/ https://www.ncbi.nlm.nih.gov/pubmed/24199178 http://dx.doi.org/10.2147/RRU.S32736

Ejemplares similares

A noninvasive multi-analyte diagnostic assay: combining protein and DNA markers to stratify bladder cancer patients
por: Fernandez, Cecilia A, et al.
Publicado: (2012)

Molecular grading of tumors of the upper urothelial tract using FGFR3 mutation status identifies patients with favorable prognosis
por: Lyle, Stephen R, et al.
Publicado: (2012)

Noninvasive multianalyte diagnostic assay for monitoring bladder cancer recurrence
por: Shore, Neal D, et al.
Publicado: (2012)

microRNA profiles in urine by next-generation sequencing can stratify bladder cancer subtypes
por: Pardini, Barbara, et al.
Publicado: (2018)

Split Hand Foot Malformation Syndrome: A Novel Heterozygous FGFR1 Mutation Detected by Next Generation Sequencing
por: Papasozomenou, Panayiota, et al.
Publicado: (2019)

Using deep learning to identify bladder cancers with FGFR‐activating mutations from histology images
por: Velmahos, Constantine S., et al.
Publicado: (2021)

Deep learning in next-generation sequencing
por: Schmidt, Bertil, et al.
Publicado: (2021)

Benefits and Challenges with Applying Unique Molecular Identifiers in Next Generation Sequencing to Detect Low Frequency Mutations
por: Kou, Ruqin, et al.
Publicado: (2016)

Estimating Exceptionally Rare Germline and Somatic Mutation Frequencies via Next Generation Sequencing
por: Eboreime, Jordan, et al.
Publicado: (2016)

Significance of the FGFR3 mutation in Chinese patients with bladder cancer
por: Hao, Lanxiang, et al.
Publicado: (2023)

Next-Generation Proteomics–Based Discovery, Verification, and Validation of Urine Biomarkers for Bladder Cancer Diagnosis
por: Suh, Jungyo, et al.
Publicado: (2022)

Methylation Markers for Urine-Based Detection of Bladder Cancer: The Next Generation of Urinary Markers for Diagnosis and Surveillance of Bladder Cancer
por: Reinert, Thomas
Publicado: (2012)

FGFR3 mutation increases bladder tumourigenesis by suppressing acute inflammation
por: Foth, Mona, et al.
Publicado: (2018)

A Novel Methylation Marker NRN1 plus TERT and FGFR3 Mutation Using Urine Sediment Enables the Detection of Urothelial Bladder Carcinoma
por: Zhang, Junjie, et al.
Publicado: (2023)

Dysbiosis of urine microbiota in obstructive urinary retention patients revealed by next-generation sequencing
por: Jiang, Shan, et al.
Publicado: (2021)

Accurate Detection of Urothelial Bladder Cancer Using Targeted Deep Sequencing of Urine DNA
por: Lee, Dongin, et al.
Publicado: (2023)

Identification of a novel mutation of FGFR3 gene in a large Chinese pedigree with hypochondroplasia by next-generation sequencing: A case report and brief literature review
por: Yao, Guixiang, et al.
Publicado: (2019)

Hybridization Capture-Based Next-Generation Sequencing to Evaluate Coding Sequence and Deep Intronic Mutations in the NF1 Gene
por: Cunha, Karin Soares, et al.
Publicado: (2016)

Analysis of error profiles in deep next-generation sequencing data
por: Ma, Xiaotu, et al.
Publicado: (2019)

Next generation deep sequencing and vaccine design: today and tomorrow
por: Luciani, Fabio, et al.
Publicado: (2012)

Datasets for next-generation sequencing of DNA and RNA from urine and plasma of patients with prostate cancer
por: Nikitina, A.S., et al.
Publicado: (2016)

Next Generation Sequencing of urine exfoliated cells: an approach of prostate cancer microRNAs research
por: Guelfi, Gabriella, et al.
Publicado: (2018)

A simple method to estimate the in-house limit of detection for genetic mutations with low allele frequencies in whole-exome sequencing analysis by next-generation sequencing
por: Miura, Takumi, et al.
Publicado: (2021)

Multiplex PCR and Next Generation Sequencing for the Non-Invasive Detection of Bladder Cancer
por: Ward, Douglas G., et al.
Publicado: (2016)

Implications of targeted next-generation sequencing for bladder cancer: report of four cases
por: Khalifa, Mohamed K., et al.
Publicado: (2021)

The Role of the Key Differentially Mutated Gene FGFR3 in the Immune Microenvironment of Bladder Cancer
por: Jiang, Jun, et al.
Publicado: (2022)

A novel ultra-sensitive method for the detection of FGFR3 mutations in urine of bladder cancer patients – Design of the Urodiag® PCR kit for surveillance of patients with non-muscle-invasive bladder cancer (NMIBC)
por: Roperch, Jean-Pierre, et al.
Publicado: (2020)

Dual targeting of FGFR3 and ERBB3 enhances the efficacy of FGFR inhibitors in FGFR3 fusion-driven bladder cancer
por: Weickhardt, Andrew J., et al.
Publicado: (2022)

Sequence variations, flanking region mutations, and allele frequency at 31 autosomal STRs in the central Indian population by next generation sequencing (NGS)
por: Dash, Hirak Ranjan, et al.
Publicado: (2021)

Rapid identification and recovery of ENU-induced mutations with next-generation sequencing and Paired-End Low-Error analysis
por: Pan, Luyuan, et al.
Publicado: (2015)

Targeted next-generation sequencing reveals high frequency of mutations in epigenetic regulators across treatment-naïve patient melanomas
por: Lee, Jonathan J., et al.
Publicado: (2015)

Detection of a novel panel of 24 genes with high frequencies of mutation in gastric cancer based on next-generation sequencing
por: Zeng, Hui-Hui, et al.
Publicado: (2022)

Targeted next-generation sequencing for routine clinical screening of mutations
por: Weaver, Jamie MJ, et al.
Publicado: (2011)

Diagnosis of Fanconi Anemia: Mutation Analysis by Next-Generation Sequencing
por: Ameziane, Najim, et al.
Publicado: (2012)

Mutation Scanning in Wheat by Exon Capture and Next-Generation Sequencing
por: King, Robert, et al.
Publicado: (2015)

Prioritization of Variants Detected by Next Generation Sequencing According to the Mutation Tolerance and Mutational Architecture of the Corresponding Genes
por: Roca, Iria, et al.
Publicado: (2018)

FGFR inhibitors in cholangiocarcinoma: what’s now and what’s next?
por: Saborowski, Anna, et al.
Publicado: (2020)

Targeted next-generation sequencing extends the phenotypic and mutational spectrums for EYS mutations
por: Gu, Shun, et al.
Publicado: (2016)

Next generation sequencing in patients with nephrolithiasis: how does it perform compared with standard urine and stone cultures?
por: Nottingham, Charles U., et al.
Publicado: (2021)

Assessment of bacterial and fungal populations in urine from clinically healthy dogs using next‐generation sequencing
por: Melgarejo, Tonatiuh, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_lngm248p4uqa6nfpndcqb1dbla